RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 44.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+44.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$783M
AUM Growth
+$86.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$13.1M
2
+$12.8M
3
+$11.5M
4
AGN
Allergan plc
AGN
+$11.2M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$11M

Top Sells

1
+$14.2M
2
+$13.8M
3
+$11.6M
4
NVCR icon
NovoCure
NVCR
+$10.8M
5
BIIB icon
Biogen
BIIB
+$7.85M

Sector Composition

1 Healthcare 89.3%
2 Financials 1.39%
3 Technology 0.15%
4 Energy 0.13%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$38.1M 4.87%
3,006,862
+584,772
2
$27.4M 3.49%
180,000
+84,987
3
$25.4M 3.25%
1,050,000
4
$23.6M 3.02%
140,238
+34,088
5
$23.1M 2.96%
165,000
+11,000
6
$22.2M 2.83%
152,000
+10,000
7
$21.4M 2.73%
647,796
+302,346
8
$20.8M 2.65%
57,746
+4,746
9
$20.5M 2.62%
100,000
+48,000
10
$19.4M 2.47%
915,000
+546,834
11
$18.6M 2.38%
1,179,900
+346,746
12
$16.7M 2.14%
179,949
-9,351
13
$16.7M 2.13%
214,115
+23,000
14
$16.6M 2.13%
85,000
-5,000
15
$16.1M 2.05%
297,400
+186,595
16
$15.6M 2%
311,803
-51,544
17
$15.5M 1.98%
245,000
+89,000
18
$14.5M 1.85%
+569,491
19
$13.4M 1.71%
115,000
-25,046
20
$13.2M 1.69%
666,528
-549,786
21
$12.6M 1.61%
155,551
-101,365
22
$12.4M 1.59%
140,000
+5,000
23
$12.4M 1.59%
85,000
-20
24
$11.8M 1.51%
130,000
-25,118
25
$10.6M 1.36%
220,000
+20,000
1
2 3 4 5